News & Updates

Show Multimedia Only

Do alpha-1 receptor blockers prevent severe COVID-19?

Do alpha-1 receptor blockers prevent severe COVID-19?

Frequent use of alpha-1 receptor blockers neither increases nor reduces the risk of uncomplicated or severe COVID-19 hospitalization in older men with or without benign prostatic hyperplasia (BPH), reveals a recent study.

03 Oct 2023

Nirmatrelvir, molnupiravir effective against Omicron in high-risk patients

Nirmatrelvir, molnupiravir effective against Omicron in high-risk patients

Treatment with either nirmatrelvir or molnupiravir helps reduce mortality and hospitalization in COVID-19 patients infected with the Omicron variant and are at high-risk of progressing to severe disease, as shown in a study.

Magnetic hydrogel micromachines eradicate biofilms in tubular implants

Magnetic hydrogel micromachines eradicate biofilms in tubular implants

Magnetic hydrogel micromachines eradicate biofilms in tubular implants

Researchers from the Chinese University of Hong Kong (CUHK) have developed magnetic hydrogel micromachines with active release of antibacterial agents for biofilm eradication in small tubular medical implants.

Liver cirrhosis tied to higher risk of herpes zoster

Liver cirrhosis tied to higher risk of herpes zoster

The risk of herpes zoster (HZ) and HZ-related hospitalization is much higher among patients with liver cirrhosis (LC), especially those who are not currently recommended for HZ vaccination, than the general population, according to a nationwide population-based study in Korea.

Chemometrics aids in analysis of interactions between antiretroviral drugs and food

Chemometrics aids in analysis of interactions between antiretroviral drugs and food

Use of a chemometric approach appears helpful in the evaluation of interactions between antiretroviral medications and food, suggests a recent study.

25 Sep 2023

Chlorpheniramine nasal spray alleviates long COVID symptoms

Chlorpheniramine nasal spray alleviates long COVID symptoms

Inhaled chlorpheniramine maleate appears to reduce the risk of prolonged post-COVID symptoms, according to a study presented at ERS Congress 2023.

Cefoperazone-sulbactam superior to piperacillin-tazobactam for severe CAP

Cefoperazone-sulbactam superior to piperacillin-tazobactam for severe CAP

Treatment with cefoperazone-sulbactam demonstrates similar efficacy to that of piperacillin-tazobactam in adult patients with severe community-acquired pneumonia (SCAP), according to a study. However, after adjusting for disease severity, cefoperazone-sulbactam appears superior to piperacillin-tazobactam.

21 Sep 2023

Budesonide falls short of improving hyposmia related to COVID-19

Budesonide falls short of improving hyposmia related to COVID-19

Local intranasal treatment with budesonide does not appear to be effective for persistent hyposmia in patients with nonsevere COVID-19, according to a study.

21 Sep 2023

1 in 25 children with COVID-19 has dengue, says study

1 in 25 children with COVID-19 has dengue, says study

A dengue coinfection is present for every 25 SARS-CoV-2 infections, a recent study involving Filipino children has found.

19 Sep 2023

Sleep problems tied to risk of COVID-19 outcomes

Sleep problems tied to risk of COVID-19 outcomes

A cross-sectional analysis has found an association between insomnia, poor sleep quality, and extremes of sleep duration and increased COVID-19 infection and hospitalization.

18 Sep 2023

Something went wrong.